Biofilm formation and susceptibility to amphotericin B and fluconazole in Candida albicans

Jundishapur Journal of Microbiology

Volumn 7, Issue 7, 2014, Pages

  Mahmoudabadi, Ali Zarei ^a   Zarrin, Majid ^a   Kiasat, Neda ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amphotericin B; Candida albicans; Fluconazole

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; RESAZURIN;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CALORIMETRY; CANDIDA ALBICANS; CANDIDURIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; FUNGUS ISOLATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; NONHUMAN; VAGINA CANDIDIASIS;

EID: 84904257968     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.17105     Document Type: Article

References (33)

1. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011;19(5):241-7.
2. Di Done L, Oga D, Krysan DJ. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. Yeast. 2011;28(8):561-8.
3. Hahnel S, Rosentritt M, Burgers R, Handel G, Lang R. Candida albicans biofilm formation on soft denture liners and efficacy of cleaning protocols. Gerodontology. 2012;29(2):e383-91.
4. LaFleur MD, Lucumi E, Napper AD, Diamond SL, Lewis K. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J Antimicrob Chemother. 2011;66(4):820-6.
5. Punithavathy PM, Nalina K, Menon T. Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin. Indian J Pathol Microbiol. 2012;55(1):72-4.
6. Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36(3):187-91.
7. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9(7):327-35.
8. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia. 2007;164(6):265-9.
9. Paul N, Mathai E, Abraham OC, Michael JS, Mathai D. Factors associated with candiduria and related mortality. J Infect. 2007;55(5):450-5.
10. Konopka K, Dorocka-Bobkowska B, Gebremedhin S, Duzgunes N. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Antonie Van Leeuwenhoek. 2010;97(4):413-7.
11. Khan MS, Ahmad I. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J Antimicrob Chemother. 2012;67(3):618-21.
12. Jin Y, Samaranayake YH, Yip HK, Samaranayake LP. Characterization of switch phenotypes in Candida albicans biofilms. Mycopathologia. 2005;160(3):191-200.
13. Jain N, Kohli R, Cook E, Gialanella P, Chang T, Fries BC. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol. 2007;73(6):1697-703.
14. Mohammadi P, Shoaie N, Roudbar Mohammadi S. Isolation and Detection of Yeast Biofilms From Urine Catheters of Infectious Patients. Jundishapur J Microbiol. 2012;5(4):533-6.
15. Tobudic S, Kratzer C, Lassnigg A, Presterl E. Antifungal susceptibility of Candida albicans in biofilms. Mycoses. 2012;55(3):199-204.
16. Tsang CS, Ng H, McMillan AS. Antifungal susceptibility of Candida albicans biofilms on titanium discs with different surface roughness. Clin Oral Investig. 2007;11(4):361-8.
17. Jafari-Nodoushan AA, Kazemi A, Mirzaii F, Dehghani M. Fluconazole Susceptibility Profile of Candida isolates Recovered From Patients Specimens Admitted to Yazd Central Laboratory. Iran J Pharmaceut Res. 2008;7(1):69-75.
18. Ahmadzadeh A, Valavi E, Shamsizadeh A, Zarei Mahmoudabadi A, Hydari M, Ahmadzadeh MA. Fungal urinary tract infection in an infant with posterior urethral valves. Jundishapur J Microbiol. 2011;4(5):.
19. Salehei Z, Seifi Z, Mahmoudabadi AZ. Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran. Jundishapur J Microbiol. 2012;5(4):574-7.
20. Oz Y, Dag I, Kiraz N. Efficacy of disinfectants on Candida biofilms at different concentrations and contact times. British Microbiol Res J. 2012;2(2):40-52.
21. Yigit N, Aktas E, Dagistan S, Ayyildiz A. Investigating Biofilm Production, Coagulase and Hemolytic Activity in Candida Species Isolated From Denture Stomatitis Patients. Eurasian J Med. 2011;43(1):27-32.
22. Paiva LC, Vidigal PG, Donatti L, Svidzinski TI, Consolaro ME. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron. 2012;43(2-3):497-502.
23. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000;13(1):122-43.
24. Samaranayake YH, Dassanayake RS, Jayatilake JA, Cheung BP, Yau JY, Yeung KW, et al. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol. 2005;54(Pt 6):583-93.
25. Frade JP, Arthington-Skaggs BA. Effect of serum and surface characteristics on Candida albicans biofilm formation. Mycoses. 2011;54(4):e154-62.
26. Silva MP, Chibebe Junior J, Jorjao AL, Machado AK, Oliveira LD, Junqueira JC, et al. Influence of artificial saliva in biofilm formation of Candida albicans in vitro. Braz Oral Res. 2012;26(1):24-8.
27. Thein ZM, Samaranayake YH, Samaranayake LP. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol. 2007;52(8):761-7.
28. Villar-Vidal M, Marcos-Arias C, Eraso E, Quindos G. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis. Enferm Infecc Microbiol Clin. 2011;29(9):660-5.
29. Sudjana AN, Carson CF, Carson KC, Riley TV, Hammer KA. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil. Med Mycol. 2012;50(8):863-70.
30. Lal P, Agarwal V, Pruthi P, Pereira BM, Kural MR, Pruthi V. Biofilm formation by Candida albicans isolated from intrauterine devices. Indian J Microbiol. 2008;48(4):438-44.
31. Negri MF, Faria MG, Guilhermetti E, Alves AA, Paula CR, Svidzinski TIE. Hemolytic activity and production of germ tubes related to pathogenic potential of clinical isolates of Candida albicans. Rev Ciênc Farm Básica. 2010;31(1):89-93.
32. Mohanty S, Xess I, Hasan F, Kapil A, Mittal S, Tolosa JE. Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis. Indian J Med Res. 2007;126(3):216-9.
33. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155-62.